These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 582795)

  • 61. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.
    Olsson B; Johansson M; Gabrielsson J; Bolme P
    Eur J Clin Pharmacol; 1988; 34(1):77-82. PubMed ID: 3360052
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers.
    Laher MS; Hickey MP
    J Int Med Res; 1985; 13(3):159-62. PubMed ID: 4007251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of the new analgesic, meptazinol, after oral and intravenous administration to volunteers.
    Norbury HM; Franklin RA; Graham DF
    Eur J Clin Pharmacol; 1983; 25(1):77-80. PubMed ID: 6617729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics of terodiline in human volunteers.
    Karlén B; Andersson KE; Ekman G; Strömberg S; Ulmsten U
    Eur J Clin Pharmacol; 1982; 23(3):267-70. PubMed ID: 7173296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bioavailability and first-pass metabolism of oral pentazocine in man.
    Ehrnebo M; Boréus LO; Lönroth U
    Clin Pharmacol Ther; 1977 Dec; 22(6):888-92. PubMed ID: 923183
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics and Pharmacodynamics of procyclidine in man.
    Whiteman PD; Fowle AS; Hamilton MJ; Peck AW; Bye A; Dean K; Webster A
    Eur J Clin Pharmacol; 1985; 28(1):73-8. PubMed ID: 3987788
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A study of the potential interactions between azapropazone and frusemide in man.
    Williamson PJ; Ene MD; Roberts CJ
    Br J Clin Pharmacol; 1984 Oct; 18(4):619-23. PubMed ID: 6487503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Excretion of azapropazone in human breast milk.
    Bald R; Bernbeck-Betthäuser EM; Spahn H; Mutschler E
    Eur J Clin Pharmacol; 1990; 39(3):271-3. PubMed ID: 2257865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics of diltiazem after intravenous and oral administration.
    Hermann P; Rodger SD; Remones G; Thenot JP; London DR; Morselli PL
    Eur J Clin Pharmacol; 1983; 24(3):349-52. PubMed ID: 6861848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of ageing on the hepatic clearance of propranolol.
    Castleden CM; George CF
    Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics of VP16-213 given by different administration methods.
    D'Incalci M; Farina P; Sessa C; Mangioni C; Conter V; Masera G; Rocchetti M; Pisoni MB; Piazza E; Beer M; Cavalli F
    Cancer Chemother Pharmacol; 1982; 7(2-3):141-5. PubMed ID: 7083454
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
    Roncari G; Ziegler WH; Guentert TW
    Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following 'high-dose' pulse administration.
    Narang PK; Wilder R; Chatterji DC; Yeager RL; Gallelli JF
    Biopharm Drug Dispos; 1983; 4(3):233-48. PubMed ID: 6626699
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Plasma azapropazone level during combination therapy of rheumatoid diseases].
    Faust-Tinnefeldt G; Geissler HE; Gilfrich HJ
    Verh Dtsch Ges Inn Med; 1978; (84):1502-5. PubMed ID: 311119
    [No Abstract]   [Full Text] [Related]  

  • 77. [Determination of azapropazone and 8-hydroxyazapropazone in urine by direct quantitative thin-layer chromatography (author's transl)].
    Geissler HE; Faust-Tinnefeldt G; Mutschler E
    Arzneimittelforschung; 1978; 28(8):1430-1. PubMed ID: 582413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Azapropazone binding to human serum albumin.
    Fehske KJ; Jähnchen E; Müller WE; Stillbauer A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):159-63. PubMed ID: 7422015
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses.
    Rietbrock N; Guggenmos J; Kuhlmann J; Hess U
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):373-9. PubMed ID: 971702
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetics and metabolism of nifedipine.
    Raemsch KD; Sommer J
    Hypertension; 1983; 5(4 Pt 2):II18-24. PubMed ID: 6862586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.